Sort   by:  
 Page size 
UnknownAlpha (B.1.1.7) and Delta (B.1.617.2 - AY.40) SARS-CoV-2 variants present strong neutralization decay at M4 post-vaccination and a faster replication rates than D614G (B.1) lineage.
Not available
S-EPMC8603409 | biostudies-literature
UnknownEarlier In Vitro Viral Production With SARS-CoV-2 Alpha Than With Beta, Gamma, B, or A.27 Variants.
Not available
S-EPMC8716835 | biostudies-literature
UnknownTransposon Insertion Sequencing in a Clinical Isolate of Legionella pneumophila Identifies Essential Genes and Determinants of Natural Transformation.
Not available
S-EPMC7811196 | biostudies-literature
UnknownEmergence of E484K Mutation Following Bamlanivimab Monotherapy among High-Risk Patients Infected with the Alpha Variant of SARS-CoV-2.
Not available
S-EPMC8402761 | biostudies-literature
UnknownEnvironmental Free-Living Amoebae Can Predate on Diverse Antibiotic-Resistant Human Pathogens.
Not available
S-EPMC8388808 | biostudies-literature
UnknownVaccine Ab neutralization against Omicron and SARS-CoV-2 variants using neutralization and specific ELISA assays.
Not available
S-EPMC8906917 | biostudies-literature
UnknownPitfalls of antiretroviral drug resistance genotyping of HIV-1 Group M and Group N from Cameroon by sequenced-based assays.
Not available
S-EPMC4743293 | biostudies-literature
UnknownHot spots of integrase genotypic changes leading to HIV-2 resistance to raltegravir.
Not available
S-EPMC3067093 | biostudies-literature
UnknownHigh prevalence of bacterial STI, anal HPV, cytological abnormalities and anal lesions among MSM in Togo, 2021: a baseline analysis of the ANRS I MIE 12,400/DepIST-H cohort.
Not available
S-EPMC12465205 | biostudies-literature
UnknownOptimizing the Use of Cabotegravir Plus Rilpivirine Long-acting Therapy in HIV Care: Evidence, Implementation, and Unanswered Questions.
Not available
S-EPMC12304414 | biostudies-literature
Sort   by:  
 Page size